1 minggu yang lalu
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) - Analysts astatine Zacks Research trim their FY2024 net per stock (EPS) estimates for Vertex Pharmaceuticals successful a investigation statement issued connected Wednesday, October 23rd. Zacks Research expert R. Department now forecasts that the…
This communicative appeared connected marketbeat.com, 2024-10-25 11:35:45.
English (US) · 
Indonesian (ID) ·